INTRODUCTION AND OBJECTIVES: Reusable ureteroscopy requires many expensive components which pose financial obstacles to centers in developing countries and domestic community centers. Lowering costs while maintaining operative quality during flexible ureteroscopy is an important goal. The Neoflex (Neoscope, USA) singleuse flexible digital ureteroscope can connect to a video processing unit (VPU), which can connect directly to the standard OR monitor. It can also connect to a portable laptop adaptor device (PLAD), which produces HD videos on any Mac/Windows-based laptop and reduce much of the equipment cost. We perform an in vitro comparison of optics and performance between these two devices. Comparisons were also done with a Flex-X 2 (Karl Storz, Germany) reusable fiberoptic ureteroscope.
METHODS: For resolution, ureteroscope tips were positioned 10 to 50 mm away from a 1951 USAF test target at 10 mm increments. Data were analyzed per protocol, with higher numbers indicating better resolution. For contrast, ureteroscopes were moved down a 15 step grayscale gradient, starting from the darkest square to the lightest, until the observer noted a change in contrast between two squares. Color representation was assessed using a Macbeth Color Chart and graded on a scale of 1 to 3 (3 being the greatest similarity). Video recording of ureteroscopic laser lithotripsy with the VPU and PLAD were also shown to different urologists (n[10) for evaluation of image quality by questionnaire.
RESULTS: There was no significant difference in resolution between the VPU and PLAD at varying distances (p[0.15). Color representation was slightly better in the VPU but contrast evaluation was similar in both devices (Table 1) . Observers deemed illumination (p<0.01) and overall performance (p[0.01) superior in the VPU, but comparable between both devices for glare, visualization, resolution and detail visibility (Table 2) . When queried on their preferred device, 40% of respondents were indifferent to using either device. Both devices were superior to the fiberoptic ureteroscope in all 3 optical characteristics.
CONCLUSIONS: In addition to the PLAD being able to produce high quality images on standard laptop setups, both devices have the added potential to provide image quality comparable to that of expensive reusable ureteroscopy equipment, at a fraction of the cost. 
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Bert Dhondt*, Glenn Vergauwen, Jan Van Deun, Edward Geeurickx, Lien Lippens, Joeri Tulkens, Ghent, Belgium; lkka Miinalainen, Pekka Rappu, Jyrki Heino Oulu, Finland, Piet Ost, Olivier De Wever, An Hendrix, Nicolaas Lumen, Ghent, Belgium INTRODUCTION AND OBJECTIVES: Extracellular vesicles (EV) have raised interest as a potential source of biomarker discovery. We developed techniques for high-purity isolation of tumor tissue EV (tEV) and urinary EV (uEV), a prerequisite for the identification of EVspecific functions and biomarkers. This study maps the biomarker potential of uEV in prostate cancer (PC).
METHODS: Urine samples from PC patients were collected prior to, and 3 months after local treatment. From 5 patients, paired urine samples and tumor tissue were collected. UEV were isolated with a discontinuous OptiPrepä density gradient (ODG). Tumor tissue was incubated for 3 hours in cell culture medium and tEV were isolated from the conditioned medium by size exclusion chromatography and ODG. UEV and tEV were characterized using nanoparticle tracking analysis (NTA), western blot (WB), transmission electron microscopy (TEM) and mass spectrometry (MS).
RESULTS: NTA, WB and TEM confirmed the enrichment of uEV and tEV in 1.1 g/ml density fractions (EV fraction), and soluble urinary proteins (SP fraction) in high density fractions. MS of paired tEV and uEV samples showed enrichment of tEV proteins in uEV, demonstrating detection of PC-derived EV in urine. MS identified biologically relevant EV-associated proteins with high repeatability. Vol. 201, No. 4S, Supplement, Friday, May 3, 2019 THE JOURNAL OF UROLOGY Ò e79
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